Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Director | September 29, 2023 | September 29, 2023 |
| COLGATE PALMOLIVE COCL · Entity 2972 | Director | October 01, 2026 | October 03, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | November 29, 2024 | December 03, 2024 |
| HERSHEY COHSY · Entity 795 | Director | April 01, 2018 | April 03, 2018 |
| TAPESTRY, INC.TPR · Entity 2309 | Director | November 14, 2024 | November 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date September 29, 2023 · Filed September 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 22,065.49 |
Reported balance
After 2023-09-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-09-29 · Grant · Acquired 1,642.03 · Balance 22,065.49 F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2: Phantom shares are fully vested. F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4: Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock.
F2: Phantom shares are fully vested.
F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination.
F4: Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report.
COLGATE PALMOLIVE CO
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,725 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 271 · Balance 40,725 F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 4,719 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,719 |
Filing footnotes · ownership attribution and instrument terms
F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
Elanco Animal Health Inc
Report date November 29, 2024 · Filed December 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,400 |
Reported balance
After 2024-11-29 transaction · row 1
1 source rowRow 1 · 2024-11-29 · Grant · Acquired 18,169 · Balance 78,400 F1: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 41,722 |
Reported balance
Holding disclosure · report date 2024-11-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 41,722 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
HERSHEY CO
Report date April 01, 2018 · Filed April 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 162,148.592 |
Reported balance
After 2018-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-04-01 · Grant · Acquired 138.578 · Balance 162,148.592 F1: The total amount of securities reported as directly owned in Column 5 includes 9.716 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 342.4674 |
Reported balance
Holding disclosure · report date 2018-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 342.4674 F2: The total amount of securities reported as indirectly owned by the reporting person includes 1.7996 shares acquired from December 1, 2017 through March 5, 2018, pursuant to the Company's 401(k) Plan ("Plan"). The information is based on a report dated March 6, 2018, provided by the Plan Trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The total amount of securities reported as directly owned in Column 5 includes 9.716 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders.
F2: The total amount of securities reported as indirectly owned by the reporting person includes 1.7996 shares acquired from December 1, 2017 through March 5, 2018, pursuant to the Company's 401(k) Plan ("Plan"). The information is based on a report dated March 6, 2018, provided by the Plan Trustee.
TAPESTRY, INC.
Report date November 14, 2024 · Filed November 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,846 |
Reported balance
After 2024-11-14 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2024-11-14 · Grant · Acquired 3,459 · Balance 47,846 F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 47,846 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 47,846 |
Filing footnotes · ownership attribution and instrument terms
F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OLAPLEX HOLDINGS, INC.
Report date July 07, 2026 · Filed July 07, 2026
Section 16 reporting ended · disclosed 2026-07-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-07 transaction · row 1
1 source rowRow 1 · 2026-07-07 · Disposition to issuer · Disposed 640,021 · Balance 0 F2: At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time. F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. |
| Common StockSEC Table I · non-derivative | IndirectBy the Amended and Restated John P. Bilbrey Revocable Declaration of Trust | 0 |
Reported balance
After 2026-07-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-07-07 · Disposition to issuer · Disposed 318,418 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law.
F2: At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:05 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 271 | $87.42 | $23,690.82 |
DisclosureSEC source: 0001225208-26-008100 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,725 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 07, 2026 Filed Jul 7, 2026 21:30 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | Disposition to issuerCommon Stock | 318,418 | $2.06 | $655,941.08 |
DisclosureSEC source: 0001193125-26-297670 · ownership.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. Read SEC document |
| July 07, 2026 Filed Jul 7, 2026 21:30 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | Disposition to issuerCommon Stock | 640,021 | $2.06 | $1,318,443.26 |
DisclosureSEC source: 0001193125-26-297670 · ownership.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · shares: At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time. F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:15 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 265 | $89.45 | $23,704.25 |
DisclosureSEC source: 0001225208-26-006373 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,229 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:45 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 2,424 | $0.00 Strike: $86.74 | $0.00 |
DisclosureSEC source: 0001225208-26-005233 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,424 Underlying: Common Stock · 2,424 shares Expires 2034-05-11 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:45 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-005233 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,820 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:04 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 266 | $89.05 | $23,687.30 |
DisclosureSEC source: 0001225208-26-004361 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,665 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 301 | $78.66 | $23,676.66 |
DisclosureSEC source: 0001225208-26-000334 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,195 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 289 | $82.13 | $23,735.57 |
DisclosureSEC source: 0001225208-25-008429 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,658 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 20:03 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | GrantCommon Stock | 294,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001868726-25-000093 · wk-form4_1755201835.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,021 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:12 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 264 | $89.91 | $23,736.24 |
DisclosureSEC source: 0001225208-25-006334 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,156 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:16 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 2,272 | $0.00 Strike: $89.14 | $0.00 |
DisclosureSEC source: 0001225208-25-005088 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,272 Underlying: Common Stock · 2,272 shares Expires 2033-05-12 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 12, 2025 grant date. Read SEC document |
| May 12, 2025 Filed May 14, 2025 20:16 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-005088 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,768 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:15 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 231 | $91.99 | $21,249.69 |
DisclosureSEC source: 0001225208-25-004005 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,688 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:15 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 228 | $93.18 | $21,245.04 |
DisclosureSEC source: 0001225208-25-000337 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,273 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028145 · form4-12032024_101210.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,400 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:04 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 51,697 | $1.75 | $90,469.75 |
DisclosureSEC source: 0001868726-24-000094 · wk-form4_1732050250.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 318,418 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.72 to $1.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:04 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 25,128 | $1.76 | $44,225.28 |
DisclosureSEC source: 0001868726-24-000094 · wk-form4_1732050250.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 266,721 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.75 to $1.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:38 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 3,459 | $57.82 | $199,999.38 |
DisclosureSEC source: 0001225208-24-009995 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,846 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 201 | $105.24 | $21,153.24 |
DisclosureSEC source: 0001225208-24-009087 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,879 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 20:29 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 183,493 | $2.05 | $376,160.65 |
DisclosureSEC source: 0001868726-24-000073 · wk-form4_1724272137.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 241,593 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.02 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 20:03 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | GrantCommon Stock | 203,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001868726-24-000057 · wk-form4_1723233773.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,903 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on July 16, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:26 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 222 | $95.61 | $21,225.42 |
DisclosureSEC source: 0001225208-24-007283 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,521 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 2,201 | $0.00 Strike: $94.46 | $0.00 |
DisclosureSEC source: 0001225208-24-006064 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,201 Underlying: Common Stock · 2,201 shares Expires 2032-05-13 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2024 grant date. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 1,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-006064 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,198 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:04 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,329 | $0.00 Strike: $62.04 | $0.00 |
DisclosureSEC source: 0001225208-24-005537 · doc4.xml · derivative · entry 4 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,329 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:04 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 6,329 | $91.59 | $579,695.89 |
DisclosureSEC source: 0001225208-24-005537 · doc4.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,236 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:04 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 6,329 | $62.04 | $392,651.16 |
DisclosureSEC source: 0001225208-24-005537 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:15 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 240 | $88.36 | $21,206.40 |
DisclosureSEC source: 0001225208-24-004870 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,236 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:16 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 271 | $78.18 | $21,186.78 |
DisclosureSEC source: 0001225208-24-000383 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,829 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:36 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015788 · form4-12042023_101213.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,231 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:48 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantStock Option · Derivative | 10,302 | $0.00 Strike: $27.33 | $0.00 |
DisclosureSEC source: 0001225208-23-009971 · doc4.xml · derivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,302 Underlying: Common Stock · 10,302 shares Expires 2033-11-02 F2 · security: All of these securities acquired were issued under the Issuer's Stock Incentive Plan. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 21:48 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 3,110 | $27.33 | $84,996.30 |
DisclosureSEC source: 0001225208-23-009971 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,282 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 2, 2024. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:20 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 292 | $72.76 | $21,245.92 |
DisclosureSEC source: 0001225208-23-009323 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,375 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 20:08 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,642.03 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-23-000124 · wk-form4_1696018105.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,065.49 Underlying: Common Stock · 1,642.03 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 21:16 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 8,100 | $2.29 | $18,549.00 |
DisclosureSEC source: 0001868726-23-000084 · wf-form4_169507176842816.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 58,100 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.29 to $2.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 15, 2023 Filed Aug 15, 2023 20:10 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 43,500 | $2.63 | $114,405.00 |
DisclosureSEC source: 0001868726-23-000081 · wf-form4_169213024439745.xml · nonDerivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 50,000 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.59 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 20:10 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | PurchaseCommon Stock | 6,500 | $2.65 | $17,225.00 |
DisclosureSEC source: 0001868726-23-000081 · wf-form4_169213024439745.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust Disclosed balance after: 6,500 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.64 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:09 UTC | OLAPLEX HOLDINGS, INC. OLPX · Entity 31605 | GrantCommon Stock | 142,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001868726-23-000075 · wf-form4_169169815147137.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,857 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on July 9, 2024, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 278 | $76.32 | $21,216.96 |
DisclosureSEC source: 0001225208-23-007357 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,907 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 29, 2023 Filed Jun 30, 2023 19:17 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,489.67 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-23-000092 · wk-form4_1688152653.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,259.86 Underlying: Common Stock · 1,489.67 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 126.27 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 2,884 | $0.00 Strike: $81.08 | $0.00 |
DisclosureSEC source: 0001225208-23-005993 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,884 Underlying: Common Stock · 2,884 shares Expires 2031-05-15 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 15, 2023 grant date. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:07 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005993 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,628 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:23 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,703 | $0.00 Strike: $71.65 | $0.00 |
DisclosureSEC source: 0001225208-23-005681 · doc4.xml · derivative · entry 4 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,703 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:23 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 5,703 | $80.81 | $460,868.55 |
DisclosureSEC source: 0001225208-23-005681 · doc4.xml · nonDerivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,257 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.81 to $80.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:23 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 5,703 | $71.65 | $408,619.95 |
DisclosureSEC source: 0001225208-23-005681 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:21 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 291 | $72.95 | $21,228.45 |
DisclosureSEC source: 0001225208-23-004677 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,257 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 30, 2023 Filed Mar 31, 2023 20:53 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,245.4 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-23-000043 · wf-form4_168029601878233.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,643.92 Underlying: Common Stock · 1,245.4 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 123.16 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:17 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 271 | $78.40 | $21,246.40 |
DisclosureSEC source: 0001225208-23-000400 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,809 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:08 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 722.8584 | $12.22 | $8,833.33 |
DisclosureSEC source: 0001415889-23-000089 · form4-01032023_100159.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,487.3487 Underlying: Common Stock · 722.8584 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F2 · price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.